Showing results (81-90 of 712) with videos related to
Sort By:
Pageof 72
Arzneimittel-Forschung|February 1, 1992
[Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin]B Simon, H Bergdolt, H G Dammann, et al.Arzneimittel-Forschung|March 1, 1990
[Endoscopic studies on the gastric tolerance of paracetamol and acetylsalicylic acid. A placebo-controlled, double-blind study in healthy volunteers]P Müller, B Simon, D Weise, et al.Arzneimittel-Forschung|July 1, 1991
[Acidity profile in humans after multiple oral administration of hydrotalcite]M Dreyer, D Marwinski, N Wolf, et al.Zeitschrift Fur Rheumatologie|September 1, 1989
[Gastroduodenal tolerance of tenoxicam versus diclofenac-Na: an endoscopy double-blind controlled study in healthy probands]P Müller, H G Dammann, E Marinis, et al.Schweizerische Medizinische Wochenschrift|June 5, 1982
[Human acid inhibition and prevention of a drop in the transmucosal potential difference by thioprostaglandin EMD 33290]H G Dammann, P Müller, J Heun, et al.Zeitschrift Fur Gastroenterologie|August 1, 1989
[Endoscopic studies of gastroduodenal tolerance of 100 mg versus 500 mg acetylsalicylic acid daily: a randomized double-blind study with healthy probands]P Müller, H G Dammann, E Marinis, et al.Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
The new histamine H2-receptor antagonist ranitidine. Duration of actionH G Dammann, P Müller, H Kather, et al.Arzneimittel-Forschung|January 1, 1982
[SKF 93479, a newly developed histamine H2-receptor antagonist. / Effect on gastric potential difference in the presence and absence of acetylsalicylic acid]P Müller, H G Dammann, R Kessler, et al.European Journal of Clinical Pharmacology|January 1, 1989
Comparison of the gastroduodenal tolerance of tenoxicam and diclofenac Na. A double-blind, endoscopically controlled study in healthy volunteersP Müller, H G Dammann, U Leucht, et al.Zeitschrift Fur Gastroenterologie|November 1, 1991
[75 mg roxatidine nocte protects human gastric mucosa against 300 mg acetylsalicylic acid nocte]B Simon, H Bergdolt, H G Dammann, et al.Pageof 72